At a glance
ClinicalIndex Comparison RecordN/ACompleted· 69 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Routine Use of Sensor-Augmented Pump Therapy - a Follow up Study
In Brief
An observational study for Diabetes. Completed, enrolled 69 participants across 1 site.
Detailed Summary
The aim of this study is to document the routine practice in continuous glucose monitoring (CGM) in patients treated with sensor-augmented pump therapy and to assess clinical outcome (HbA1c) before the start of the sensor use to the end of the follow-up period. Moreover, data on treatment satisfaction, and fear of hypoglycemia, cost of the therapy, side effects and treatment interruption will be collected.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesSweden
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2011
First PostedOct 2011
Primary CompletionNov 2011
Study CompletionDec 2011
TodayJul 2026
First PostedOct 13, 2011
Enrollment StartJun 1, 2011
Primary CompletionNov 1, 2011
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 14.7 years ago